OLANZACCORD TABLETS

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Buy It Now

Active ingredient:

Olanzapine

Available from:

Accord Healthcare Pty Ltd

Class:

Medicine Registered

Patient Information leaflet

                                OLANZACCORD TABLETS 
CONSUMER MEDICINE INFORMATION
                                
                                             
                                             
                                Version: 1.0    
                    
-2012-                                          
                                             
                                    Page: 1 of 6
 
 
 
 
 
 
 
  
 
OLANZACCORD TABLETS  
Olanzapine Tablets  
CONSUMER MEDICINE INFORMATION 
 
WHAT IS IN THIS LEAFLET  
 
This leaflet is designed to 
provide you with answers to 
some common questions about 
this medicine. It does not contain 
all the available information and 
does not take the place of talking 
with your doctor.  
 
More recent information about 
this medicine may be available. 
Make sure you speak to your 
pharmacist or doctor to obtain 
the most up to date information 
on this medicine.  
 
All medicines have risks and 
benefits.  
Your doctor has more 
information about this medicine 
than is contained in this leaflet. 
Also, your doctor has had the 
benefit of taking a full and 
detailed history from you and is 
in the best position to make an 
expert judgement to meet your 
individual needs.  
 
IF YOU HAVE ANY CONCERNS ABOUT 
TAKING THIS MEDICINE, TALK TO 
YOUR DOCTOR OR PHARMACIST.  
 
KEEP THIS LEAFLET WITH THIS 
MEDICINE.  
 
You may need to read it again. 
 
WHAT OLANZACCORD 
TABLETS ARE USED FOR  
 
Olanzaccord Tablets belongs to a 
group of medicines called 
antipsychotics. It helps to correct 
chemical imbalances in the brain, 
which may cause mental illness. 
Olanzaccord Tablets are used to 
treat symptoms of schizophrenia 
and related psychoses. 
Schizophrenia is a mental illness 
with disturbances in thinki
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                Olanzaccord Tablets (Olanzapine Tablets)                   
                                   Version 1.0 
 
 
-2012-                                          
                                             
                     Page: 1 of 22
    
 
 
PRODUCT INFORMATION 
OLANZACCORD TABLETS  
(OLANZAPINE TABLETS) 
 
NAME OF THE MEDICINE  
Olanzapine 
 
Chemically, olanzapine is
2-methyl-4-(4-methyl-1-piperazinyl)-10_H_-thieno[2,3-_b_] 
[1,5]benzodiazepine and its empirical formula is C
17
H
20
N
4
S. Olanzapine is a yellow 
crystalline solid, practically insoluble in water with a molecular
weight of 312.44. The 
CAS number for olanzapine is 132539-06-1. 
 
Structural formula:  
 
 
 
DESCRIPTION  
Olanzaccord Tablets 2.5 mg are presented as white to off white,
round, biconvex, film-
coated tablets, debossed with “O” on one side and plain on the
other side. 
 
Olanzaccord Tablets 5 mg are presented as white to off white,
round, biconvex, film-
coated tablets, debossed with “O1” on one side and plain on the
other side. 
 
Olanzaccord Tablets 7.5 mg are presented as white to off white,
round, biconvex, film-
coated tablets, debossed with “O2” on one side and plain on the
other side. 
 
Olanzaccord Tablets 10 mg are presented as white to off white, round,
biconvex, film-
coated tablets, debossed with “O3” on one side and plain on the
other side. 
 
 
 
Olanzaccord Tablets (Olanzapine Tablets)                   
                                   Version 1.0 
 
 
-2012-                                          
                                             
                     Page: 2 of 22
    
 
 
 
Olanzaccord Tablets 15 mg are presented as light blue, elliptical,
biconvex, film-coated 
tablets debossed with “O4” on one side and plain on the other
side. 
 
T
                                
                                Read the complete document
                                
                            

Search alerts related to this product